- Home
- MRK vs MS Comparison
MRK vs MS Comparison
Compare MRK & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- MS
- Stock Information
- Founded
- MRK 2000
- MS 1924
- Country
- MRK United States
- MS United States
- Employees
- MRK N/A
- MS N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- MS Investment Bankers/Brokers/Service
- Sector
- MRK Health Care
- MS Finance
- Exchange
- MRK Nasdaq
- MS Nasdaq
- Market Cap
- MRK 218.2B
- MS 209.6B
- IPO Year
- MRK N/A
- MS N/A
- Fundamental
- Price
- MRK $79.11
- MS $132.68
- Analyst Decision
- MRK Buy
- MS Buy
- Analyst Count
- MRK 15
- MS 15
- Target Price
- MRK $113.71
- MS $133.62
- AVG Volume (30 Days)
- MRK 13.9M
- MS 4.8M
- Earning Date
- MRK 07-29-2025
- MS 07-16-2025
- Dividend Yield
- MRK 4.10%
- MS 2.79%
- EPS Growth
- MRK 667.14
- MS 55.47
- EPS
- MRK 6.88
- MS 8.53
- Revenue
- MRK $63,922,000,000.00
- MS $63,959,000,000.00
- Revenue This Year
- MRK $2.42
- MS $10.14
- Revenue Next Year
- MRK $5.76
- MS $4.06
- P/E Ratio
- MRK $11.50
- MS $15.54
- Revenue Growth
- MRK 4.10
- MS 17.42
- 52 Week Low
- MRK $73.31
- MS $90.94
- 52 Week High
- MRK $134.63
- MS $142.03
- Technical
- Relative Strength Index (RSI)
- MRK 49.58
- MS 62.86
- Support Level
- MRK $77.10
- MS $129.66
- Resistance Level
- MRK $82.44
- MS $132.80
- Average True Range (ATR)
- MRK 1.82
- MS 2.14
- MACD
- MRK 0.19
- MS -0.23
- Stochastic Oscillator
- MRK 52.63
- MS 87.66
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About MS Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 24% of its total revenue is from outside the Americas. The company had over $6 trillion of client assets as well as around 70,000 employees at the end of 2024.